Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910143745703321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910830522603321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicines from animal cell culture / / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture / / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910877693903321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
